Hemodynamic Effects of Sacubitril/Valsartan in Patients with Reduced Left Ventricular Ejection Fraction Over 24 Months: A Retrospective Study

BACKGROUND: The effects of sacubitril/valsartan in patients with chronic heart failure with reduced ejection fraction (HFrEF) were recently reported. However, the hemodynamic impact of this well-established treatment in patients with HFrEF has been poorly systematically researched. AIM: We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Abumayyaleh, Mohammad, Demmer, Jonathan, Krack, Carina, Pilsinger, Christina, El-Battrawy, Ibrahim, Behnes, Michael, Aweimer, Assem, Mügge, Andreas, Lang, Siegfried, Akin, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468101/
https://www.ncbi.nlm.nih.gov/pubmed/35353351
http://dx.doi.org/10.1007/s40256-022-00525-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468101/
https://www.ncbi.nlm.nih.gov/pubmed/35353351
http://dx.doi.org/10.1007/s40256-022-00525-w

Ejemplares similares